139 related articles for article (PubMed ID: 29312511)
1. The long non-coding RNA SUMO1P3 facilitates breast cancer progression by negatively regulating miR-320a.
Liu J; Song Z; Feng C; Lu Y; Zhou Y; Lin Y; Dong C
Am J Transl Res; 2017; 9(12):5594-5602. PubMed ID: 29312511
[TBL] [Abstract][Full Text] [Related]
2. SUMO1P3 is associated clinical progression and facilitates cell migration and invasion through regulating miR-136 in non-small cell lung cancer.
Zhang Y; Li Y; Han L; Zhang P; Sun S
Biomed Pharmacother; 2019 May; 113():108686. PubMed ID: 30851548
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA SUMO1P3 promotes tumour progression by regulating cell proliferation and invasion in glioma.
Deng D; Mo Y; Xue L; Shao N; Cao J
Exp Ther Med; 2021 May; 21(5):491. PubMed ID: 33791000
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA SUMO1P3 may promote cell proliferation, migration, and invasion of pancreatic cancer via EMT signaling pathway.
Tian C; Jin Y; Shi S
Oncol Lett; 2018 Nov; 16(5):6109-6115. PubMed ID: 30333879
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of serum exosomal SUMO1P3 predicts unfavorable prognosis in triple negative breast cancer.
Na-Er A; Xu YY; Liu YH; Gan YJ
Eur Rev Med Pharmacol Sci; 2021 Jan; 25(1):154-160. PubMed ID: 33506903
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of SUMO1P3 predicts poor prognosis and promotes tumor growth and metastasis in bladder cancer.
Zhan Y; Liu Y; Wang C; Lin J; Chen M; Chen X; Zhuang C; Liu L; Xu W; Zhou Q; Sun X; Zhang Q; Zhao G; Huang W
Oncotarget; 2016 Mar; 7(13):16038-48. PubMed ID: 26799188
[TBL] [Abstract][Full Text] [Related]
7. LncRNA SUMO1P3 drives colon cancer growth, metastasis and angiogenesis.
Zhang LM; Wang P; Liu XM; Zhang YJ
Am J Transl Res; 2017; 9(12):5461-5472. PubMed ID: 29312498
[TBL] [Abstract][Full Text] [Related]
8. The long noncoding RNA SUMO1P3 as urinary biomarker for monitoring bladder cancer progression.
Galbiati S; Bettiga A; Colciago G; Senti C; Trevisani F; Villa G; Marzinotto I; Ghidini M; Passalacqua R; Montorsi F; Salonia A; Vago R
Front Oncol; 2024; 14():1325157. PubMed ID: 38846969
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of lncRNA SUMO1P3 promotes proliferation, invasion and drug resistance in gastric cancer through interacting with the CNBP protein.
Guo Y; Wang Y; Ma Y; Chen G; Yue P; Li Y
RSC Adv; 2020 Feb; 10(10):6006-6016. PubMed ID: 35497433
[TBL] [Abstract][Full Text] [Related]
10. Up-regulation of SUMO1 pseudogene 3 (SUMO1P3) in gastric cancer and its clinical association.
Mei D; Song H; Wang K; Lou Y; Sun W; Liu Z; Ding X; Guo J
Med Oncol; 2013 Dec; 30(4):709. PubMed ID: 23996296
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of SUMO1P3 represses tumor growth and invasion and enhances radiosensitivity in hepatocellular carcinoma.
Zhou Y; He P; Xie X; Sun C
Mol Cell Biochem; 2019 Jan; 450(1-2):125-134. PubMed ID: 29905911
[TBL] [Abstract][Full Text] [Related]
12. Rab14 Suppression Mediated by MiR-320a Inhibits Cell Proliferation, Migration and Invasion in Breast Cancer.
Yu J; Wang L; Yang H; Ding D; Zhang L; Wang J; Chen Q; Zou Q; Jin Y; Liu X
J Cancer; 2016; 7(15):2317-2326. PubMed ID: 27994670
[TBL] [Abstract][Full Text] [Related]
13. LncRNA SUMO1P3 promotes proliferation and inhibits apoptosis in colorectal cancer by epigenetically silencing CPEB3.
Lin H; Guo Q; Lu S; Chen J; Li X; Gong M; Tang L; Wen J
Biochem Biophys Res Commun; 2019 Apr; 511(2):239-245. PubMed ID: 30799082
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-320a is downregulated in non-small cell lung cancer and suppresses tumor cell growth and invasion by directly targeting insulin-like growth factor 1 receptor.
Wang J; Shi C; Wang J; Cao L; Zhong L; Wang D
Oncol Lett; 2017 May; 13(5):3247-3252. PubMed ID: 28521431
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA RNCR3 promotes prostate cancer progression through targeting miR-185-5p.
Tian C; Deng Y; Jin Y; Shi S; Bi H
Am J Transl Res; 2018; 10(5):1562-1570. PubMed ID: 29887969
[TBL] [Abstract][Full Text] [Related]
16. Decreased expression of microRNA-320a promotes proliferation and invasion of non-small cell lung cancer cells by increasing VDAC1 expression.
Zhang G; Jiang G; Wang C; Zhong K; Zhang J; Xue Q; Li X; Jin H; Li B
Oncotarget; 2016 Aug; 7(31):49470-49480. PubMed ID: 27304056
[TBL] [Abstract][Full Text] [Related]
17. Long Non-Coding RNA (LncRNA) UFC1/miR-34a Contributes to Proliferation and Migration in Breast Cancer.
Xie R; Wang M; Zhou W; Wang D; Yuan Y; Shi H; Wu L
Med Sci Monit; 2019 Sep; 25():7149-7157. PubMed ID: 31544897
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-320a inhibits breast cancer metastasis by targeting metadherin.
Yu J; Wang JG; Zhang L; Yang HP; Wang L; Ding D; Chen Q; Yang WL; Ren KH; Zhou DM; Zou Q; Jin YT; Liu XP
Oncotarget; 2016 Jun; 7(25):38612-38625. PubMed ID: 27229534
[TBL] [Abstract][Full Text] [Related]
19. Expression of SUMO1P3 Compared with SUMO1 is an Independent Predictor of Patient Outcome in Lung Adenocarcinoma.
Su X; Wan Y; Xie L; Lin X; Zhao H; Ju X; Fang A
Med Sci Monit; 2019 Sep; 25():6691-6701. PubMed ID: 31489957
[TBL] [Abstract][Full Text] [Related]
20. HIF-1α Induces HECTD2 Up-Regulation and Aggravates the Malignant Progression of Renal Cell Cancer
Lv D; Shen T; Yao J; Yang Q; Xiang Y; Ma Z
Front Cell Dev Biol; 2021; 9():775642. PubMed ID: 35004677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
